×
About 85,872 results

ADZENYS XR-ODT® (amphetamine tablets)
http://adzenysxrodthcp.com/

Find information on Adzenys XR-ODT delivery system, dosing, adverse reactions, and safety data. Learn about savings and support available to your patients. View Important Safety Information including Boxed WARNING for abuse and dependence.

ADRENACLICK® (epinephrine injection, USP auto-injector)
http://epinephrineautoinject.com/healthcare-professionals/

Adrenaclick (epinephrine injection, USP auto-injector) is an emergency injection (shot) of epinephrine used for the treatment of life-threatening allergic reactions known as anaphylaxis. With numbered and color-coded instructions, Adrenaclick is designed for single-dose use by patients and caregivers in an anaphylactic

ADRENALIN® (epinephrine injection)
http://parsterileproducts.com/products/products/adrenalin-injection.php

Adrenalin is a non-selective alpha and beta adrenergic agonist indicated for emergency treatment of allergic reactions (Type 1), including anaphylaxis.

BACTROBAN NASAL (mupirocin calcium ointment, 2%) for intranasal use only
https://gsksource.com/pharma/content/gsk/source/us/en/brands/bactroban-nasal.html

BACTROBAN nasal ointment is an RNA synthetase inhibitor antibacterial indicated for the ... The most frequent adverse reactions (at least 1% in US trials) were ...

DUPIXENT®(dupilumab)
https://www.dupixenthcp.com/

DUPIXENT® is for your adult patients with uncontrolled moderate-to-severe atopic dermatitis. Learn more now. Adverse reactions may occur. Please see Important Safety Information and full PI on website.

ELAPRASE® (idursulfase) INJECTION
http://www.elaprase.com/hcp/

Enzyme replacement therapy for Hunter syndrome. See Important Safety Info regarding Boxed Warning about life-threatening anaphylactic reactions.

FLUZONE® HIGH DOSE INFLUENZA VACCINE
http://www.fluzone.com/health-care-professionals/index.cfm

The most common local and systemic adverse reactions to Fluzone Quadrivalent, Fluzone Intradermal Quadrivalent, and Fluzone High-Dose vaccines include pain and swelling at the injection site (also pruritus at the injection site and shivering in adults receiving Fluzone Intradermal Quadrivalent vaccine); myalgia, malaise ...

HUMALOG 200 KWIKPEN (insulin lispro injection)
https://www.humalog.com/hcp/humalog-u200/

Humalog U-200 should not be transferred from the Humalog KwikPen to a syringe as overdose and severe hypoglycemia can occur. Hypersensitivity Reactions: Severe, life-threatening, generalized allergy, including anaphylaxis, can occur with Humalog, Humalog Mix75/25, and Humalog Mix50/50. If hypersensitivity ...

OFEV® (nintedanib) capsules
https://www.ofevhcp.com/

Visit the official HCP website for OFEV (nintedanib), a treatment option for your patients with idiopathic pulmonary fibrosis (IPF), by Boehringer Ingelheim. Adverse reactions may occur. Please see full prescribing information, including patient information, and important safety information on this website.

NAFTIN (naftifine hydrochloride) Gel
http://www.naftin.com/hcp-index.html

A fungicidal allylamine that attacks offending microorganisms—highest efficacy observed at 6 weeks (4 weeks post last treatment)3; Adverse events comparable to vehicle3: Application site reactions were the most common adverse reactions seen in clinical trials with NAFTIN® Gel, 2% (2%) vs vehicle (1%).

PRAXBIND® (idarucizumab) INJECTION, FOR INTRAVENOUS USE
https://www.praxbind.com/

Product information on treatment with PRAXBIND, the ONLY FDA-approved specific reversal agent for a NOAC available in all 50 states. Adverse reactions may occur with PRAXBIND. View Important Safety Information and Full Prescribing Information on website.

Flector® Patch (diclofenac epolamine topical patch) 1.3%
https://www1.pfizerpro.com/product/flectorpatch/acute-pain

FLECTOR Patch is contraindicated in patients with known hypersensitivity (e.g., ... and serious skin reactions) to diclofenac or any components of the drug product. ... FLECTOR Patch is indicated for the topical treatment of acute pain due to ...

ALREX® (loteprednol etabonate ophthalmic suspension)
http://www.bausch.com/ecp/our-products/rx-pharmaceuticals/rx-pharmaceuticals/alrex-loteprednol-etabonate-ophthalmic-suspension-02

Alrex ophthalmic suspension (loteprednol etabonate ophthalmic suspension) 0.2% is indicated for temporary relief of the signs and symptoms of seasonal allergic conjunctivitis. ... Ocular adverse reactions occurring in 5-15% of patients treated with loteprednol etabonate ophthalmic ...

CETYLEV® (acetylcysteine)
http://cetylev.com/

Hypersensitivity reactions, including generalized urticaria have been observed in patients receiving oral acetylcysteine overdose. If hypersensitivity reactions occur, Cetylev should be discontinued unless it is deemed essential for patient management and the reactions can be otherwise controlled.

CHANTIX® TABLETS (varenicline)
https://www1.pfizerpro.com/product/chantix/hcp

CHANTIX is contraindicated in patients with a history of serious hypersensitivity or skin reactions to CHANTIX. Postmarketing reports of serious or clinically significant neuropsychiatric adverse events have been reported in patients treated with CHANTIX. These included changes in mood (including depression and mania)

RADICAVA (edaravone injection)
https://www.radicava.com/hcp/

In the treatment of ALS every move matters. ... Radicava® (edaravone) is contraindicated in patients with a history of hypersensitivity to edaravone or any of the inactive ingredients in Radicava®. ... To report suspected adverse reactions or product complaints, contact Mitsubishi Tanabe ...

VISTOGARD® (uridine triacetate) ORAL GRANULES
https://www.vistogard.com/Professional/Home

Limitations of use. VISTOGARD® is not recommended for the non-emergent treatment of adverse reactions associated with fluorouracil or capecitabine because it may diminish the efficacy of these drugs. The safety and efficacy of VISTOGARD initiated more than 96 hours following the end of fluorouracil or capecitabine ...

TAKHZYRO™ (lanadelumab-flyo
https://www.takhzyro.com/hcp#takhzyro

Learn more about TAKHZYRO™ (lanadelumab-flyo). Find out how TAKHZYRO works, how to get patients started with the Quick Start Program and how to sign up for updates. See Important Safety Information, including injection site reactions.

ZERBAXA® (ceftolozane and tazobactam) INJECTION
https://www.merckconnect.com/zerbaxa/overview.html

Access resources about ZERBAXA® (ceftolozane and tazobactam) and find information about efficacy, adverse reactions, microbiology, and more.

ZIPSOR (diclofenac potassium) CAPSULES
https://www.zipsor.com/hcp/

The most common adverse reactions reported in ZIPSOR clinical trials include abdominal pain, constipation, diarrhea, dyspepsia, nausea, vomiting, dizziness, headache, somnolence, pruritus, and increased sweating. Please see Important Safety Information and full Prescribing Information, including BOXED WARNING.